Clinical Trial Update: Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A [Phase 3]

View source ↗

Summary

An ongoing Phase 3 clinical trial is evaluating the combination of natamycin and cyclosporine A for fungal keratitis and corneal ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Fungal Keratitis

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Natamycin (natamycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Fungal Keratitis, Corneal Ulcer | Phase 3 | Status: RECRUITING